Skip to main content
EJNMMI Research
Fig. 6 | EJNMMI Research

Fig. 6

From: The effects of novel macrocyclic chelates on the targeting properties of the 68Ga-labeled Gastrin releasing peptide receptor antagonist RM2

Fig. 6

Maximum intensity projection of the whole-body coronal micro-PET/CT images of a BALB/c nu/nu male mouse bearing a PC3 tumor xenograft. Time-dependent static scans demonstrated the tumor-targeting efficacy of 68Ga-X-RM2 at 30, 60, and 120 min post-injection of 68Ga-DOTA-RM2 (a), 68Ga-DATA5m-RM2 (b) and 68Ga-AAZTA5-RM2 (c). Approximately 2.6 MBq/mice were injected

Back to article page